Cargando…
Metformin Suppresses Hypopharyngeal Cancer Growth by Epigenetically Silencing Long Non-coding RNA SNHG7 in FaDu Cells
Local recurrence after therapy remains a challenging problem for hypopharyngeal cancer (HPC) due to the chemotherapy resistance. Metformin is associated with reduced cancer risk through promoting global DNA methylation in cancer cells by controlling S-adenosylhomocysteine (SAHH) activity. However, t...
Autores principales: | Wu, Ping, Tang, Yaoyun, Fang, Xing, Xie, Chubo, Zeng, Junfeng, Wang, Wei, Zhao, Suping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395377/ https://www.ncbi.nlm.nih.gov/pubmed/30853913 http://dx.doi.org/10.3389/fphar.2019.00143 |
Ejemplares similares
-
(+)-Usnic acid modulates the Nrf2-ARE pathway in FaDu hypopharyngeal carcinoma cells
por: Krajka-Kuźniak, Violetta, et al.
Publicado: (2021) -
The effect and mechanism of action of metformin on in vitro FaDu cell proliferation
por: Sun, Ruijie, et al.
Publicado: (2016) -
Downregulation of RNA binding motif protein 17 expression inhibits proliferation of hypopharyngeal carcinoma FaDu cells
por: Han, Yuefeng, et al.
Publicado: (2018) -
TBX3 knockdown suppresses the proliferation of hypopharyngeal carcinoma FaDu cells by inducing G1/S cell cycle arrest and apoptosis
por: Huang, Yongjiu, et al.
Publicado: (2020) -
Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade
por: Yen, Chia-Sheng, et al.
Publicado: (2016)